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www.rsc.org/catalysisDeracemisation of profenol core by combining
laccase/TEMPO-mediated oxidation and alcohol
dehydrogenase-catalysed dynamic kinetic resolution†
Alba Díaz-Rodríguez,*a Nicolás Ríos-Lombardía,a Johann H. Sattler,b
Iván Lavandera,a Vicente Gotor-Fernández,a Wolfgang Kroutilb and Vicente Gotor*aA mild one-pot methodology has been developed to deracemise
rac-2-phenyl-1-propanol by combining the use of non-selective
laccase/TEMPO-mediated oxidation with enantioselective bio-
reduction of the racemic aldehyde intermediate under dynamic
conditions. The process was easily scalable and stereocontrollable
by selecting the suitable biocatalyst.
The preparation of an enantiomerically pure product in 100%
yield from an inexpensive racemate in a one-pot fashion has
gained significant attention via biocatalytic deracemisation
processes.1 Among the toolbox of enzymes of interest, oxido-
reductases occupy a prominent position.2 In the last few
years, the number of examples in which these enzymes have
been successfully used with synthetic purposes has increased
significantly, showing their high versatility.3 In fact, oxidore-
ductases have been proven useful for a set of transformations
even on the industrial scale, especially for the preparation of
enantiopure alcohol intermediates.4
Driven by the need to enhance the atom economy of
chemical transformations, especial interest has been focused
on the development of (bio)catalytic transformations that
combine two or more processes in one-pot.5 On the one
hand, alcohol dehydrogenases (ADHs) have been successfully
employed together with other (bio)catalysts in chemo-
enzymatic routes currently employed for the generation of
various pharmaceuticals.6 On the other hand, laccases are
attracting the attention of synthetic chemists since they con-
sume molecular oxygen to oxidise, e.g. phenolic compounds;7
nevertheless, primary and secondary alcohols are also
oxidised in the presence of a mediator. Therefore, laccaseshave found a number of applications in academia and
industry.8
Herein, we report a multienzymatic approach for the
deracemisation of the β-chiral alcohol 2-phenyl-1-propanol
rac-1, the key core of NSAID drugs, by combining two redox
processes in a stepwise or one-pot fashion. Other methodolo-
gies have been achieved for the deracemisation of mainly sec-
ondary alcohols using whole cells or enantiocomplementary
ADHs.2c,9 Here, the designed redox sequence involves the
non-stereoselective oxidation of rac-1 by a laccase/TEMPO
system10 to the chiral labile aldehyde rac-2, followed by selec-
tive reduction with an ADH in a dynamic kinetic resolution
process (DKR, Scheme 1). While the DKR of rac-2 has been
performed in the presence of alcohol dehydrogenases such as
horse liver ADH (HLADH)11 or Sulfolobus solfataricus ADH
(SsADH),12 these previous approaches start with the aldehyde
although racemic alcohol rac-1 is more accessible and cheaper
than the corresponding aldehyde. Moreover, aldehyde 2 isl., 2015, 5, 1443–1446 | 1443
emisation of profenol 1 in (a)
change in pH to favour the
a two-step two-pot fashion
ermediate after an extraction
ers; I and J are intermediate
namic process.
Table 1 Conversions and ee for the ADH-catalysed bioreduction of
rac-2a
Entry ADH c (%) ee (%)
1 HLADH >97 90 (S)
2 ADH-P >97 94 (S)
3 ADH-T >97 8 (S)
4 LBADH 96 48 (S)
5 SyADH >97 50 (S)
6 RasADH >97 10 (S)
7 ADH-A 95 6 (S)
8 Evo-1.1.200 >97 68 (R)
a Reactions were performed at 30 mM substrate concentration, pH
8 and 30 °C, conversions were determined by GC and enantiomeric
excesses were determined by chiral HPLC.
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View Article Onlineunstable and has been proven to undergo decarboxylation.13
It is very important to note that in previous reports, only the
enantiomer (S)-1 was obtained; therefore the development of a
methodology that could afford both enantiomers is of inter-
est.14 Additionally, the previous example that used HLADH
with this substrate was performed at 0.5 mM concentration,
which is not convenient for synthetic purposes.11b
The laccase/TEMPO system,10,15 e.g. Trametes versicolor
laccase/TEMPO, has already been described for the selective
transformation of racemic 2-phenyl-1-propanol Ĳrac-1, Scheme 2)
to 2-phenylpropionaldehyde Ĳrac-2) in a very good yield (85%).15h
Nevertheless, aldehyde 2 was obtained as a racemate.
First, we studied the laccase-catalysed process in detail
(see the ESI,† Tables S1 and S2). At a substrate concentration
of 30 mM, the oxidation of rac-1 gave rac-2 in 85% yield after
2 h employing laccase from T. versicolor and TEMPO
(Table S2†). Under these conditions, we also observed the
formation of racemic 2-phenylpropionic acid rac-3 (15%,
Scheme 2) which was tried to be minimised. Thus, the oxida-
tion reaction was run at a more elevated substrate concentra-
tion (90 mM), leading to a decrease in the undesired carbox-
ylic acid (<7%, Table S2†).
Focusing now on the enantioselective reduction step
(Scheme 3), we tested a number of ADHs available in our
laboratory to find the best candidates for the deracemisation
protocol. Initial experiments showed that ADH from E. coli
(ADH-P)16 and HLADH11a were the best options for obtaining
(S)-1 with 94% and 90% ee, respectively (entries 1–2, Table 1).
On the other hand, Evo-1.1.200 (ref. 17) led to the other anti-
pode (R)-1 although with moderate selectivity (entry 8, Table 1).
In all these cases, ethanol or 2-propanol was employed as a
cosubstrate for cofactor recycling in a “coupled-substrate”
mode.1444 | Catal. Sci. Technol., 2015, 5, 1443–1446
Scheme 2 Oxidation of 2-phenyl-1-propanol Ĳrac-1) using the
laccase/TEMPO catalytic system.
Scheme 3 ADH-catalysed reduction of rac-2 to obtain either (S)-1 or
(R)-1.Then, additional experiments were carried out in order to
enhance the enantiomeric excess of (R)-1 (entries 1–4,
Table 2). A considerable improvement was observed with
Evo-1.1.200 when the bioreduction was performed at pH 9
(≥90% (R), entries 1 and 2, Table 2). In fact, (R)-selective
Evo-1.1.200 showed an improved enantioselection with
increasing temperature or/and pH. Remarkably, despite the
increase in ee for the desired alcohol (R)-1, the formation
of acetophenone 4 as a by-product13 was also detected under
more drastic conditions (entries 2–4, Table 2). Blank reac-
tions using aldehyde 2 indicated that this compound was not
stable at elevated temperatures or pH values. Thus, pH 9 and
a temperature of 30 °C were chosen for Evo-1.1.200 (entry 1,
Table 2). Similar experiments were performed for HLADH
(entries 5–8, Table 2) and ADH-P (ESI,† Table S4). However,
these bioprocesses did not show any improvement at higher
pH values or temperatures so a pH 8 and 30 °C were further
used for HLADH (entry 5, Table 2).
After these initial studies, a stepwise procedure was inves-
tigated. Thus, after the laccase-mediated oxidation, the bio-
reduction was carried out without isolating the aldehyde
intermediate, thus the extracted crude product from the oxi-
dation was directly used in the reduction. In general, the
overall transformation of rac-1 into enantioenriched (R)- or
(S)-1 proceeded similarly well with HLADH and Evo-1.1.200,
resulting in high conversions (>95%) and good ee values
(86–87%, entries 1–2, Table 3). Remarkably, only traces of theThis journal is © The Royal Society of Chemistry 2015
Table 2 Bioreduction of racemic aldehyde 2 at different pH values and
temperatures
Entry ADH Conditions ca (%) eeb (%)
1 Evo-1.1.200 pH 9, 30 °C >97 (5) 90 (R)
2 Evo-1.1.200 pH 9, 60 °C >97 (10) 94 (R)
3 Evo-1.1.200 pH 10, 30 °C 97 (6) 88 (R)
4 Evo-1.1.200 pH 10, 45 °C 90 (10) >97 (R)
5 HLADH pH 8, 30 °C >97 (5) 90 (S)
6 HLADH pH 8, 60 °C >97 (16) 94 (S)
7 HLADH pH 9, 30 °C >97 (14) 88 (S)
8 HLADH pH 10, 30 °C >97 (14) 94 (S)
a Conversions were determined by GC and the percentage of
acetophenone appears in brackets. b Enantiomeric excesses were
determined by chiral HPLC.
Table 3 Deracemisation of rac-1 to (R)- or (S)-1 in a stepwise or one-pot
reaction sequencea
Entry ADH 1b 2 4 ee (%)
1c Evo-1.1.200 75 5 20 86 (R)
2c HLADH 87 <1 12 87 (S)
3c ADH-P 79 10 10 88 (S)
4d Evo-1.1.200 85 (72) 7 8 86 (R)
5d HLADH 84 (71) <1 16 82 (S)
a Conversions were determined by GC and enantiomeric excesses
were determined by chiral HPLC. b Isolated yields appear in brackets.
c Stepwise transformation. d One-pot transformation.
Catalysis Science & Technology Communication
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
2 
Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
on
 1
3/
05
/2
01
6 
08
:1
6:
42
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinecarboxylic acid were observed in these two-step processes.
For ADH-P, this reaction did not run to completion (entry 3).
Consequently, these transformations were carried out in
one-pot. As the initial experiments indicated that both reac-
tions could proceed on a preparative scale, the deracemisations
were performed on a 150 mg scale. For this purpose, the
non-stereoselective oxidation of 1 (90 mM) with laccase/
TEMPO was left for 3.5 h in citrate buffer at pH 5.5 and, after
that time, the solution was diluted with a phosphate buffer
and the pH was adjusted (pH 8 for HLADH and pH 9 for
Evo.1.1.200; final substrate concentration = 30 mM). Since
the laccase was not active at pH 8, overoxidation of the
enantioenriched aldehyde was negligible. Finally, the NADH
cofactor (1 mM) and cosubstrate (5% v/v) were added. The
reaction products were isolated in 71 and 72% yield and ee =
82–86% for both enantiomers (entries 4–5, Table 3). Signifi-
cantly, the optical purity of the resulting alcohol 1 decreased
in comparison with the values obtained from the single bio-
reduction reaction (Table 2), which can be caused by side-
oxidation reactions18 during the sequence and the loss of the
ADH efficiency at prolonged times.
In an attempt to broaden the scope of this methodology,
ibuprofenol and naproxenol were also tried as substrates
under laccase/TEMPO-catalysed oxidative conditions. Unfortu-
nately, we found some solubility issues for both alcohols,
obtaining mixtures of the corresponding aldehydes and car-
boxylic acids to a similar extent in the Trametes versicolor
laccase-mediated transformation. Using a plain buffer as a
solvent or different quantities of a cosolvent such as methyl
tert-butyl ether or acetonitrile did not overcome this limita-
tion (data not shown). Medium engineering studies will be
necessary to select more appropriate oxidative conditions and
will be reported in due course.
Conclusions
In summary, a new strategy to deracemise 2-phenyl-1-propanol
was described by combining a chemoenzymatic approach
for the non-selective oxidation of this alcohol, followed by
dynamic reductive kinetic resolution of the aldehyde interme-
diate. The cascade reaction consisted of aerobic oxidation
mediated by laccase from Trametes versicolor and TEMPO,
while the stereoselective reduction of the corresponding race-
mic aldehyde intermediate was mediated by an ADH underThis journal is © The Royal Society of Chemistry 2015dynamic conditions. These intermediates have been proven
to be unstable, so the use of a sequential or one-pot dera-
cemisation procedure starting from the stable racemic alcohol
is highly desirable. Using this methodology, both enantiomers
were accessible by using two stereocomplementary ADHs,
mainly HLADH and Evo-1.1.200. This strategy was successfully
carried out on a preparative scale (150 mg), therefore repre-
senting a powerful synthetic route for the preparation of opti-
cally active profenol-like compounds.
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